Takahashi Shoko from Genequest Inc. in Tokyo is developing a large DNA database for personalized healthcare, while Yamayoshi Asako at the Institute of Science Tokyo in Yokohama is innovating drug delivery using exosomes to target tumors, potentially improving treatment outcomes and reducing costs. Teljes cikk (Euronews.com)